GeneNews Ltd (TSE:GEN) was down 13.3% during mid-day trading on Thursday . The company traded as low as C$0.12 and last traded at C$0.13. Approximately 1,032,049 shares were traded during trading, a decline of 38% from the average daily volume of 1,659,144 shares. The stock had previously closed at C$0.15.
The stock has a market capitalization of $22.10 million and a PE ratio of -4.14.
About GeneNews (TSE:GEN)
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Further Reading: Gap Up Stocks
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.